/
/
/

Colinz Laboratories Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)72.93
Volume (₹)16.00
High (₹)73.65
Upper Circuit75.07
Low (₹)72.93
Lower Circuit67.93
Prev Close71.50
52W High (₹)87.91
Price73.65
52W Low (₹)36.11

Share Market Cap & Key Ratios Overview

M.Cap (₹)18.01 Cr
Div. Yield (%)0.00
PE Ratio6.44
Debt to Equity0.04
Price to Book1.12
Book Value39.87
EPS (TTM)11.10
Face Value10.00
ROE (%)5.27

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
COLINZ-XTNSE
LTP
1W Low
1W High
Market cap (₹)
1907.15-12.95 (-0.67%)
1901
1964.85
4,56,833Cr
9188.5-80.5 (-0.87%)
9051.85
9296
2,45,426Cr
4914.35-120.65 (-2.40%)
4890
5049
1,87,320Cr
1134.45-52.55 (-4.43%)
1126
1191.45
1,13,217Cr
1387.1-30.9 (-2.18%)
1377
1426.20
1,12,212Cr
1861.65-73.65 (-3.81%)
1812
1947.90
1,01,155Cr
2124.9-50.1 (-2.30%)
2117.80
2209
97,626Cr
2359.85-27.55 (-1.15%)
2323.15
2407.40
96,859Cr
1164.1-13.7 (-1.16%)
1155
1179.90
96,406Cr
1648.45-1.55 (-0.09%)
1623.05
1706.70
93,614Cr
73.65-0.35 (-0.47%)
69.25
74.99
18Cr

Key Highlights of Colinz Laboratories Ltd Balance Sheet

Colinz Laboratories Ltd balance sheet discloses shareholders' funds of ₹2.52Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹2.52Cr, and the reserves and surplus of the company is ₹7.52Cr.

The company has its non-current liabilities with total liabilities of ₹12.78Cr as of 2026-03-31.

The current liabilities are ₹2.57Cr as of 2026-03-31. At the same time, current assets are ₹10.08Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹1.11Cr and tangible assets of ₹1.54Cr, provided in the Colinz Laboratories Ltd financial statements.